UM

Browse/Search Results:  1-10 of 10 Help

Selected(0)Clear Items/Page:    Sort:
Editorial: Network Pharmacology and Traditional Medicine Journal article
FRONTIERS IN PHARMACOLOGY, 2020
Authors:  Lai, Xinxing;  Wang, Xin;  Hu, Yuanjia;  Su, Shibing;  Li, Wenqing;  Li, Shao
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/08/31
Active Ingredients and Action Mechanisms of Yi Guan Jian Decoction in Chronic Hepatitis B Patients with Liver Fibrosis Journal article
Evidence-Based Complementary and Alternative Medicine, 2019,Volume: 2019
Authors:  Guangyao Li;  Yuan Zhou;  Daniel Man-Yuen Sze;  Chao Liu;  Qianru Zhang;  Zihao Wang;  Hua Yu;  Ging Chan;  Zhongdao Wu;  Shibing Su;  Yuanjia Hu
Favorite |  | TC[WOS]:5 TC[Scopus]:9 | Submit date:2020/01/06
Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis Journal article
BIOMEDICINE & PHARMACOTHERAPY, 2019
Authors:  Cai, Feifei;  Bian, Yanqin;  Wu, Rong;  Sun, Yang;  Chen, Xiaole;  Yang, Mengdie;  Zhang, Qianru;  Hu, Yuanjia;  Sun, Mingyu;  Su, Shibing
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/08/31
Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-beta/Smad/ERK Signalling Pathway Journal article
SCIENTIFIC REPORTS, 2018
Authors:  Cai, Feifei;  Wu, Rong;  Song, Yanan;  Xiong, Aizhen;  Chen, Xiaole;  Yang, Mengdie;  Yang, Li;  Hu, Yuanjia;  Sun, Mingyu;  Su, Shibing
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/08/31
A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: An example of Yu Ping Feng decoction Journal article
SCIENTIFIC REPORTS, 2018,Volume: 8
Authors:  Zuo, Huali;  Zhang, Qianru;  Su, Shibing;  Chen, Qilong;  Yang, Fengqing;  Hu, Yuanjia
Favorite |  | TC[WOS]:40 TC[Scopus]:41 | Submit date:2018/10/30
MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis Journal article
SCIENTIFIC REPORTS, 2017,Volume: 7
Authors:  Liu, Yamin;  Wang, Mei;  Luo, Yunquan;  Chen, ChenJian;  Lu, Yiyu;  Shi, Yulin;  Tang, Chenchen;  Zhou, Qianmei;  Zhang, Hui;  Hu, Yuanjia;  Su, Shibing;  Chen, Qilong
Favorite |  | TC[WOS]:0 TC[Scopus]:16 | Submit date:2018/10/30
Precision Medical Treatment in Traditional Chinese Medicine Journal article
Journal of Alternative Complementary & Integrative Medicine, 2017
Authors:  Chen, Jian;  Hu, Xueqing;  Chen, Qilong;  Hu, Yuanjia;  Su, Shibing
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2022/08/31
An analysis of evolutionary conservation based on genomic orthology and protein-protein interaction networks Book chapter
出自: Biotechnology in Hong Kong Volume III, Whitestone, New York:United State-China Itelletual Property Institute Inc, 2017, 页码: 49-60
Authors:  Hui Hens Lin;  Pengpeng Li;  Xiangjun Kong;  Jing Cai;  Shibing Su;  Yuanjia Hu;  Hui Hens Lin;  Pengpeng Li;  Xiangjun Kong;  Jing Cai;  Shibing Su;  Yuanjia Hu
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2019/01/14
Protein-protein Interaction Networks  Evolutionary Conservation  Orthologs  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
MABS, 2017,Volume: 9,Issue: 7,Page: 1041-1051
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date:2020/05/08
Pharmaceutical Companies  Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Technological Innovation  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
MABS, 2017,Volume: 9,Issue: 7,Page: 1041-1051
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite |  | TC[WOS]:2 TC[Scopus]:2 | Submit date:2018/10/30
Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Pharmaceutical Companies  Technological Innovation